|
Small caps round-up: Ten Alps/BT, Monitise, Plethora…
ShareCast, UK - 8 hours ago Plethora Solutions's final analysis of its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation met … |
|
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
PR-Inside.com (Pressemitteilung), Austria - Nov 9, 2008 European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met its three co-primary endpoints … |
|
PRESS DIGEST – British business press – Nov 8
Forbes, NY - 22 hours ago Shares in Plethora Solutions rose 8.5 pence to 24 pence after the company announced positive phase III trials for its treatment for premature ejaculation. … In the know: JJB Sports, Shire, Vodafone and Plethora Solutions Times Online all 2 news articles |
|
Plethora's European Phase III premature ejaculation study meets …
Pharmaceutical Business Review - Nov 7, 2008 … (p<0.0001) and a six point difference between PSD502 and placebo in the index of premature ejaculation (IPE) domain for sexual satisfaction (p<0.0001), … |
|
In the know: JJB Sports, Shire, Vodafone and Plethora Solutions
Times Online, UK - 15 hours ago Plethora Solutions soared 8½p to 24p after the healthcare group announced positive phase III trials results for its treatment for premature ejaculation. … |
|
London pre-open: Slim loss to start
ShareCast, UK - 36 minutes ago Urology drug specialsit Plethora Solutions says its key premature ejaculation drug has met all of its goals in a European phase III trial. … |
 Business Wire (press release) |
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
Business Wire (press release), CA - Nov 7, 2008 There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five … Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK all 14 news articles |
|
Friday's news and tips
Investors Chronicle, UK - Nov 7, 2008 Urology drug specialist Plethora Solutions says its key premature ejaculation drug has met all of its goals in a European phase III trial. … |
|
Plethora premature ejaculation drug meets goals
Reuters UK, UK - Nov 6, 2008 L: Quote, Profile, Research) said on Friday its premature ejaculation drug has met all of its goals in a phase III trial. The company said PSD502, … Sciele Pharma and Plethora Solutions Announce Positive Phase III … Business Wire (press release) Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK Plethora hits target in European trial ShareCast Hemscott - GrowthBusiness.co.uk all 14 news articles |